These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17125207)

  • 1. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion.
    Wang J; Krudy G; Xie XQ; Wu C; Holland G
    J Chem Inf Model; 2006; 46(6):2674-83. PubMed ID: 17125207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSPR correlation of melting point for drug compounds based on different sources of molecular descriptors.
    Modarresi H; Dearden JC; Modarress H
    J Chem Inf Model; 2006; 46(2):930-6. PubMed ID: 16563024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of cyclodextrins for enhancing oral bioavailability.
    Carrier RL; Miller LA; Ahmed I
    J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-free drug-likeness from fragments.
    Ursu O; Oprea TI
    J Chem Inf Model; 2010 Aug; 50(8):1387-94. PubMed ID: 20726597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSPR models for the prediction of apparent volume of distribution.
    Ghafourian T; Barzegar-Jalali M; Dastmalchi S; Khavari-Khorasani T; Hakimiha N; Nokhodchi A
    Int J Pharm; 2006 Aug; 319(1-2):82-97. PubMed ID: 16698204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melting point prediction employing k-nearest neighbor algorithms and genetic parameter optimization.
    Nigsch F; Bender A; van Buuren B; Tissen J; Nigsch E; Mitchell JB
    J Chem Inf Model; 2006; 46(6):2412-22. PubMed ID: 17125183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(2):460-3. PubMed ID: 17381169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of binding affinities to beta1 isoform of human thyroid hormone receptor by genetic algorithm and projection pursuit regression.
    Ren Y; Liu H; Li S; Yao X; Liu M
    Bioorg Med Chem Lett; 2007 May; 17(9):2474-82. PubMed ID: 17337187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic overview of chemoinformatics.
    Engel T
    J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated in silico analysis of drug-binding to human serum albumin.
    Estrada E; Uriarte E; Molina E; Simón-Manso Y; Milne GW
    J Chem Inf Model; 2006; 46(6):2709-24. PubMed ID: 17125211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico identification of bioisosteric functional groups.
    Ertl P
    Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explorations into modeling human oral bioavailability.
    Wang Z; Yan A; Yuan Q; Gasteiger J
    Eur J Med Chem; 2008 Nov; 43(11):2442-52. PubMed ID: 18603330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.